Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Substances from stem cells for the treatment of (neuro-) degenerative diseases

02.11.2012
The new active agents can be used to produce

pharmaceutical substances to be used for the treatment of neurodegenerative diseases. The substances are enriched with dying stem cells. The agents are suited to disable acute or delayed dysfunctions. They prevent

the dying of neuronal cells after acute injuries or during the progress of neurodegenerative disorders.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2960&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht EO-Silicon - Inducing the electrooptic effect in silicon
21.01.2015 | TechnologieAllianz e.V.

nachricht Energy efficient, adaptive cups for medical technology and pharmaceutical products
20.01.2015 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Better prospects through equal opportunity

26.01.2015 | Event News

2000 Erziehungswissenschaftler an der Uni Kassel erwartet

19.01.2015 | Event News

How are Europe’s landscapes influenced by the changing energy sector?

19.01.2015 | Event News

 
Latest News

No direct link found between rising inequality and reduced trust

28.01.2015 | Social Sciences

Pilotless Aircraft Will Play Critical Roles in Precision Agriculture

28.01.2015 | Agricultural and Forestry Science

Supercomputing the evolution of a model flower

28.01.2015 | Agricultural and Forestry Science

VideoLinks
B2B-VideoLinks
More VideoLinks >>>